| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 05/03/2022 | 10:09 | TipRanks | Orasure Technologies (OSUR) Receives a Hold from J.P. Morgan | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/02/2022 | 22:45 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/02/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up | NASDAQ:OSUR | OraSure Technologies Inc |
| 16/02/2022 | 22:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/02/2022 | 22:50 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 10/02/2022 | 15:07 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/02/2022 | 22:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/01/2022 | 13:53 | Dow Jones News | OraSure Gets Approval for Covid-19 Tests on Children 2 to 14 Years Old | NASDAQ:OSUR | OraSure Technologies Inc |
| 31/01/2022 | 13:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App | NASDAQ:OSUR | OraSure Technologies Inc |
| 25/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe | NASDAQ:OSUR | OraSure Technologies Inc |
| 13/01/2022 | 22:05 | GlobeNewswire Inc. | InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/01/2022 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces Actions to Enhance Stockholder Value | NASDAQ:OSUR | OraSure Technologies Inc |
| 14/12/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces 2022 Annual Meeting Date | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2021 | 22:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OSUR | OraSure Technologies Inc |
| 30/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus | NASDAQ:OSUR | OraSure Technologies Inc |
| 19/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies to Present at Upcoming Investor Conferences | NASDAQ:OSUR | OraSure Technologies Inc |
| 09/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/11/2021 | 14:06 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OSUR | OraSure Technologies Inc |
| 08/11/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies Appoints Two New Members to the Board of Directors | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/11/2021 | 21:05 | GlobeNewswire Inc. | OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22 | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/11/2021 | 14:36 | Dow Jones News | OraSure Up 7% After FDA Authorizes Covid-19 Rapid Tests for OTC Single-Use, At-Home Testing | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/11/2021 | 12:05 | GlobeNewswire Inc. | U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection | NASDAQ:OSUR | OraSure Technologies Inc |
| 27/10/2021 | 13:05 | GlobeNewswire Inc. | OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET | NASDAQ:OSUR | OraSure Technologies Inc |
| 04/10/2021 | 13:05 | GlobeNewswire Inc. | OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test | NASDAQ:OSUR | OraSure Technologies Inc |
| 23/09/2021 | 14:10 | GlobeNewswire Inc. | OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver | NASDAQ:OSUR | OraSure Technologies Inc |
| 20/09/2021 | 13:44 | TipRanks | OraSure Procures $205M Contract from Defense Logistics Agency | NASDAQ:OSUR | OraSure Technologies Inc |
| 20/09/2021 | 12:00 | GlobeNewswire Inc. | OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response | NASDAQ:OSUR | OraSure Technologies Inc |
| 02/09/2021 | 13:00 | GlobeNewswire Inc. | OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan | NASDAQ:OSUR | OraSure Technologies Inc |
| 05/08/2021 | 22:28 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OSUR | OraSure Technologies Inc |
| 03/08/2021 | 22:05 | GlobeNewswire Inc. | OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business | NASDAQ:OSUR | OraSure Technologies Inc |